Momentum investing revolves around the idea of following a stock's recent trend in either direction. In "long context," investors will be essentially be "buying high, but hoping to sell even higher." With this methodology, taking advantage of trends in a stock's price is key; once a stock establishes a course, it is more than likely to continue moving that way. The goal is that once a stock heads down a fixed path, it will lead to timely and profitable trades.Even though momentum is a popular stock characte ...

Company Overview - Cementos Pacasmayo (NYSE:CPAC) is a leading cement company in Peru, focusing on the production and distribution of cement, concrete, and other construction materials, primarily in the northern region of Peru [1] Market Performance - The current market price of CPAC is $10.48, reflecting a modest increase of 1.95% or $0.20, with a trading range today between $10.23 and $10.69, indicating some volatility [3] - Over the past year, CPAC has experienced a high of $11.30 and a low of $5.10, showcasing its potential for growth [3] - The company's market capitalization is approximately $897.5 million, with a trading volume of 49,293 shares [3] Investment Outlook - Scotiabank has set a price target of $12.80 for CPAC, suggesting a potential increase of approximately 22.14% from its current price [2][5] - Zacks Investment Research identifies CPAC as a potential interest for value investors, supported by its strong performance in the "Value" category of Zacks' Style Scores system [2][4][5]

Cementos Pacasmayo (NYSE:CPAC) is a leading cement company in Peru, known for its production and distribution of cement, concrete, and other construction materials. The company plays a significant role in the construction industry, competing with other major players in the region. On December 19, 2025, Scotiabank maintained its "Sector Perform" rating for CPAC, suggesting investors hold their positions. At that time, the stock was priced at $10.42.Scotiabank also raised its price target for CPAC from $6.40 ...

Company Overview - Cementos Pacasmayo (CPAC) is currently rated with a Zacks Rank of 2 (Buy) and has a Value grade of A, indicating strong potential for value investors [4] - The stock has a P/E ratio of 10.03, significantly lower than the industry average P/E of 23.97, suggesting it may be undervalued [4] - Over the past 52 weeks, CPAC's Forward P/E has fluctuated between a high of 13.10 and a low of 7.26, with a median of 8.91, further indicating its valuation dynamics [4] Valuation Metrics - The P/S ratio for CPAC stands at 1.58, compared to the industry average P/S of 3.38, reinforcing the notion that the stock is undervalued [5] - The P/S ratio is favored by value investors as it is less susceptible to manipulation compared to earnings figures, making it a reliable performance indicator [5] Investment Outlook - The combination of CPAC's strong earnings outlook and its favorable valuation metrics positions it as an impressive value stock at the moment [6]

U.S. stocks traded mostly lower this morning, with the Dow Jones index falling more than 250 points on Tuesday.The Dow traded down 0.52% to 48,164.83 while the NASDAQ fell 0.37% to 22,971.25. The S&P 500 also fell, dropping, 0.56% to 6,778.08.Check This Out: Jim Cramer: Sell This Major Energy Stock, Go With This Canadian Mining CompanyLeading and Lagging SectorsCommunication services shares rose by 0.2% on Tuesday.In trading on Tuesday, energy stocks fell by 2.3%.Top HeadlineThe S&P Global flash composite P ...

Group 1 - U.S. stocks experienced a decline, with the Dow Jones index dropping over 100 points on Tuesday [1] - Cementos Pacasmayo SAA – ADR shares surged 47.4% to $10.30 following Holcim's agreement to acquire 50.01% of its owner, Inversiones Aspi. S.A. [1] Group 2 - Rezolve AI PLC reported preliminary December revenue results, leading to a 23.7% increase in its stock price to $2.87 [2] - Emerald Holding Inc announced a review of potential strategic options, resulting in a 17% rise in its stock price to $4.14 [2] - NovaBay Pharmaceuticals Inc's stock increased by 16.2% to $3.15 [2] - Tilray Brands Inc saw a 15% surge in its stock price to $12.57 [2] - Clearpoint Neuro Inc's stock jumped 14.2% to $14.14 [2] - Fermi Inc gained 11.4%, reaching $9.57 [2] - Sezzle Inc authorized a $100 million stock buyback, leading to a 9.6% increase in its stock price to $72.49 [2] - WW International Inc launched a new platform for the GLP-1 era, resulting in a 7.8% gain to $26.19 [2] - Circle Internet Group Inc rose 7.7% to $81.24 [2] - Lemonade Inc's stock surged 7.4% to $80.59 [2] - Netskope Inc gained 6.9%, reaching $20.37 [2] - Ascentage Pharma Group International's stock rose 6% to $29.26 [2] - RH's stock increased by 5.5% to $172.60, with Barclays analyst maintaining an Overweight rating and lowering the price target from $385 to $283 [2] - Affirm Holdings Inc gained 4.4%, reaching $68.56 [2]

Group 1 - Holcim will acquire a majority stake in the target company [1] - The deal values the target company at $1.5 billion [1]

Investors interested in Construction stocks should always be looking to find the best-performing companies in the group. Is Pacasmayo (CPAC) one of those stocks right now? Let's take a closer look at the stock's year-to-date performance to find out.Pacasmayo is a member of our Construction group, which includes 92 different companies and currently sits at #14 in the Zacks Sector Rank. The Zacks Sector Rank considers 16 different sector groups. The average Zacks Rank of the individual stocks within the group ...

Core Viewpoint - Pacasmayo (CPAC) has experienced a significant downtrend, with a 13.1% decline over the past four weeks, but it is now in oversold territory, suggesting a potential turnaround due to improved earnings expectations from analysts [1]. Group 1: Technical Indicators - The Relative Strength Index (RSI) is a key technical indicator used to identify oversold conditions, with a reading below 30 indicating that a stock may be oversold [2]. - CPAC's current RSI reading is 27.11, indicating that the heavy selling pressure may be exhausting, and a price reversal could occur soon [5]. Group 2: Fundamental Indicators - Analysts have raised their earnings estimates for CPAC by 14.5% over the last 30 days, which typically correlates with price appreciation in the near term [7]. - CPAC holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate revisions and EPS surprises, further supporting the potential for a turnaround [8].

Core Viewpoint - Pacasmayo (CPAC) has received an upgrade to a Zacks Rank 2 (Buy), indicating a positive outlook based on rising earnings estimates, which are a significant factor influencing stock prices [1][2]. Earnings Estimates and Stock Price Movement - The Zacks rating system is effective for individual investors as it reflects changes in earnings estimates, which are strongly correlated with near-term stock price movements [2][3]. - Institutional investors often rely on earnings estimates to determine a company's fair value, leading to significant stock price movements based on their buying or selling activities [3]. Business Improvement Indicators - The upgrade in Pacasmayo's rating suggests an improvement in the company's underlying business, which should encourage investors to drive the stock price higher [4]. - Over the past three months, the Zacks Consensus Estimate for Pacasmayo has increased by 14.5%, indicating a positive trend in earnings estimates [7]. Zacks Rank System Overview - The Zacks Rank system classifies stocks into five groups based on earnings estimates, with a proven track record of Zacks Rank 1 stocks generating an average annual return of +25% since 1988 [6]. - The system maintains a balanced distribution of "buy" and "sell" ratings, ensuring that only the top 20% of stocks receive a "Strong Buy" or "Buy" rating, highlighting their superior earnings estimate revisions [8][9].